Medications
It is very important to seek emergency
medical attention for
stroke symptoms. If you are having an
ischemic stroke
, which is caused by a blood clot, you may be given medicines that
get rid of the clot. If you are having a
hemorrhagic
stroke, which is caused by bleeding in the
brain, you will not be given medicines.
If you are having an
ischemic stroke, you may be able to receive tissue plasminogen activator
(t-PA), a clot-dissolving medicine. This medicine is strongly recommended, but
it is most effective if given within 3 hours of the onset of stroke
symptoms.1 If you receive t-PA within this 3-hour
window, it may improve your recovery. Evidence shows that there may be some
benefit in giving t-PA even beyond 3 hours.9, 10, 11 But t-PA can be life-threatening
because it can cause bleeding in the brain. It is not used to treat hemorrhagic
stroke.
Blood clots cause most strokes, so medicines that prevent
the formation of blood clots are used to prevent additional ischemic strokes.
These medicines are usually given after the initial treatment for stroke. They
are not recommended in the first 24 hours after t-PA has been given. The two
types of medicines used to prevent clotting are:
-
Antiplatelet medicines, which prevent
the smallest cells in blood (platelets) from sticking together.
Aspirin is the antiplatelet medicine most commonly used to prevent strokes.
People who cannot take aspirin or who have
transient ischemic attacks (TIAs) or a stroke while
taking aspirin are sometimes given other antiplatelet medicines, such as
clopidogrel (Plavix). Another medicine that can prevent ischemic stroke is
Aggrenox, which is aspirin combined with extended-release dipyridamole. Aspirin
is not recommended within the first 24 hours of giving t-PA. For more
information, see:
Should I take daily aspirin to prevent a heart attack or a stroke?
-
Anticoagulants, which prevent the
production of proteins needed for blood to clot normally. Anticoagulants
(particularly warfarin) are the best method of preventing blood clots that form
in the heart because of
atrial fibrillation,
heart attack, heart valve problems, or
heart failure. Anticoagulants are not given as
emergency treatment for stroke. If you take warfarin (such as Coumadin), see:
Anticoagulants: Vitamin K and your diet.- Safety tips when taking anticoagulants.
For people with
coronary artery disease, treatment with
cholesterol-lowering drugs called
statins can slow the development of
atherosclerosis in the
carotid arteries and may also reduce the chance of
having a TIA or stroke. Studies have shown a reduced risk of stroke in people
taking statins.5, 12, 6 (For more information on statins, see the topic
High Cholesterol.)
Medication Choices
Medicine used in the emergency treatment of stroke caused
by a clot (ischemic stroke) includes
tissue plasminogen activator (t-PA), a medicine that
breaks up clots.
After emergency treatment for a stroke, the focus
will turn to preventing future transient ischemic attacks (TIAs) or another
stroke. Your doctor will decide which medicines to use based on the risks and
possible side effects of the medicines. These medicines are not usually given
until at least 24 hours after treatment with t-PA.
Antiplatelet medicines
Antiplatelets
decrease blood clot formation by preventing the smallest blood cells (platelets) from sticking together and forming blood
clots. Antiplatelet medicines include the following:
- Aspirin with extended-release dipyridamole
(Aggrenox) is used for the prevention of ischemic stroke.
- Aspirin
is an antiplatelet medicine often used for a first TIA or ischemic stroke or if
you have atherosclerosis. Talk with your doctor before you start taking aspirin
to prevent a stroke.
- Clopidogrel (Plavix) may be used if you have
had a TIA or ischemic stroke and cannot take aspirin.
Anticoagulant medicines
Anticoagulants
(warfarin and heparin) are often used instead of or in combination with
antiplatelets, such as aspirin or clopidogrel. Anticoagulants are used for
people who are at risk for stroke because of:
- Abnormal heart rhythms (atrial
fibrillation).
- Heart attack, if a clot is present in the
heart.
- Heart failure.
- Abnormal or artificial heart
valves.
If you have high blood pressure, your doctor may
want you to take medicines to lower it. Blood pressure medicines
include:
Medicines used to treat depression and pain may be
prescribed after a stroke.
Medicines to lower cholesterol (statins) may be prescribed after a stroke.
What To Think About
Choosing which medicine to use
to prevent stroke is based on evaluation of your risks and the benefits of
taking that medicine. The American College of Physicians recommends:
- Warfarin for people who are at risk for
stroke because of abnormal heart rhythms (atrial fibrillation) or blood clots that form in the heart or another place in
the body. Warfarin is usually given to people age 65 and
older.
- Aspirin for people who have had a transient ischemic attack
(TIA). Talk with your doctor before you start taking aspirin to prevent a
stroke.
- Other antiplatelet medicines, such as aspirin with
extended-release dipyridamole (Aggrenox) or clopidogrel (Plavix).
Adams HP Jr, et al. (2007). Guidelines for the early
management of adults with ischemic stroke: A guideline from the American Heart
Association/American Stroke Association Stroke Council, Clinical Cardiology
Council, Cardiovascular Radiology and Intervention Council, and the
Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in
Research Interdisciplinary Working Groups: The American Academy of Neurology
affirms the value of this guideline as an educational tool for neurologists.
Stroke, 38(5): 1655–1711.
Fung TT, et al. (2004). Prospective study of major
dietary patterns and stroke risk in women. Stroke, 35:
2014–2019.
Wassertheil-Smoller S, et al. (2003). Effect of
estrogen plus progestin on stroke in postmenopausal women. The Women's Health
Initiative: A randomized trial. JAMA, 289(20):
2673–2684.
American Heart Association (2008). Heart disease and stroke statistics—2008 update (At-A-Glance version). Available online: http://www.americanheart.org/presenter.jhtml?identifier=3037327.
Stroke Prevention by Aggressive Reduction in
Cholesterol Levels (SPARCL) Investigators (2006). High-dose atorvastatin after
stroke or transient ischemic attack. New England Journal of Medicine, 355(6): 549–559.
O'Regan C, et al. (2007). Statin therapy in stroke
prevention: A meta-analysis involving 121,000 patients. American Journal of Medicine, 121(1): 24–33.
U.S. Department of Health and Human Services (2008).
2008 Physical Activity Guidelines for Americans (ODPHP
Publication No. U0036). Washington, DC: U.S. Government Printing Office.
Available online:
http://www.health.gov/paguidelines/pdf/paguide.pdf.
Lee CD, et al. (2003). Physical activity and stroke
risk: A meta-analysis. Stroke, 34(10):
2475–2481.
The ATLANTIS, ECASS, and NINDS rt-PA Study Group
Collaborative (2004). Association of outcome with early stroke treatment:
Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.
Lancet, 363(9411): 768–774.
Hacke W, et al. (2008). Thrombolysis with alteplase 3
to 4.5 hours after acute ischemic stroke. New England Journal of Medicine, 359(13): 1317–1329.
Wahlgren N, et al. (2008). Thrombolysis with alteplase
3-4.5 h after acute ischemic stroke (SITS-ISTR): An observational study.
Lancet. Published online September 15, 2008
(doi:10.1016/S0140-6736(08)61339-2).
Heart Protection Study Collaborative Group (2004).
Effects of cholesterol-lowering with simvastatin on stroke and other major
vascular events in 20,536 people with cerebrovascular disease or other
high-risk conditions. Lancet, 363(9411):
757–767.
Biller J, et al. (1998). Guidelines for carotid
endarterectomy: A statement for healthcare professionals from a special writing
group of the Stroke Council of the American Heart Association. Circulation, 97(5): 501–509.
Mayer SA, et al. (2005). Subarachnoid hemorrhage. In
LP Rowland, ed., Merritt's Neurology, 11th ed., pp.
328–338. Philadelphia: Lippincott Williams and Wilkins.
Yadav JS, et al. (2004). Protected carotid-artery
stenting versus endarterectomy in high-risk patients. New England Journal of Medicine, 351(15): 1493–1501.
Mas J-L, et al. (2006). Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. New England Journal of Medicine, 355(16): 1660–1671.
Brahmanandam S, et al. (2008). Clinical results of
carotid artery stenting compared with carotid endarterectomy. Journal of Vascular Surgery, 47(2): 343–349.